BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14616969)

  • 1. Epigenetic alteration of the SOCS1 gene in chronic myeloid leukaemia.
    Liu TC; Lin SF; Chang JG; Yang MY; Hung SY; Chang CS
    Br J Haematol; 2003 Nov; 123(4):654-61. PubMed ID: 14616969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic alteration of the SOCS1 gene in hepatocellular carcinoma.
    Chu PY; Yeh CM; Hsu NC; Chang YS; Chang JG; Yeh KT
    Swiss Med Wkly; 2010; 140():w13065. PubMed ID: 20648401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of suppressor of cytokine signaling-3 due to methylation results in phosphorylation of STAT3 in imatinib resistant BCR-ABL positive chronic myeloid leukemia cells.
    Al-Jamal HA; Jusoh SA; Yong AC; Asan JM; Hassan R; Johan MF
    Asian Pac J Cancer Prev; 2014; 15(11):4555-61. PubMed ID: 24969884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SOCS-1 gene methylation in chronic myeloid leukemia patients.
    Hatirnaz O; Ure U; Ar C; Akyerli C; Soysal T; Ferhanoğlu B; Ozçelik T; Ozbek U
    Am J Hematol; 2007 Aug; 82(8):729-30. PubMed ID: 17315216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between methylation of tumor suppressor gene SOCS1 and acute myeloid leukemia.
    Zhang XH; Yang L; Liu XJ; Zhan Y; Pan YX; Wang XZ; Luo JM
    Oncol Rep; 2018 Aug; 40(2):1008-1016. PubMed ID: 29916533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia.
    Chen CY; Tsay W; Tang JL; Shen HL; Lin SW; Huang SY; Yao M; Chen YC; Shen MC; Wang CH; Tien HF
    Genes Chromosomes Cancer; 2003 Jul; 37(3):300-5. PubMed ID: 12759928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant DNA Methylation of SOCS1 Gene is Not Associated with Resistance to Imatinib Mesylate among Chronic Myeloid Leukemia Patients.
    Elias MH; Azlan H; Baba AA; Ankathil R
    Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):234-238. PubMed ID: 29669505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.
    Capello D; Deambrogi C; Rossi D; Lischetti T; Piranda D; Cerri M; Spina V; Rasi S; Gaidano G; Lunghi M
    Br J Haematol; 2008 May; 141(4):504-11. PubMed ID: 18318760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic dysregulation of the Jak/STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias.
    Chim CS; Wong AS; Kwong YL
    Ann Hematol; 2004 Aug; 83(8):527-32. PubMed ID: 14762685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JunB gene expression is inactivated by methylation in chronic myeloid leukemia.
    Yang MY; Liu TC; Chang JG; Lin PM; Lin SF
    Blood; 2003 Apr; 101(8):3205-11. PubMed ID: 12506033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus X protein upregulates DNA methyltransferase 3A/3B and enhances SOCS-1CpG island methylation.
    Fu X; Song X; Li Y; Tan D; Liu G
    Mol Med Rep; 2016 Jan; 13(1):301-8. PubMed ID: 26573490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Down-regulation of transcription factor PU.1 via abnormal epigenetic modification in chronic myeloid leukemia].
    Yang H; Yan JS; Tao R; Hao SG; Liang H; Ma LY
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):169-75. PubMed ID: 22780968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia.
    Qian J; Wang YL; Lin J; Yao DM; Xu WR; Wu CY
    Eur J Haematol; 2009 Feb; 82(2):119-23. PubMed ID: 19018866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How frequent is SOCS1 methylation in acute myeloid leukaemia?
    Chim CS; Kwong YL
    Br J Haematol; 2004 Dec; 127(5):609-11. PubMed ID: 15566368
    [No Abstract]   [Full Text] [Related]  

  • 15. Methylation status of CEBPA gene promoter in chronic myeloid leukemia.
    Annamaneni S; Kagita S; Gorre M; Digumarti RR; Satti V; Battini MR
    Hematology; 2014 Jan; 19(1):42-4. PubMed ID: 23541085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia.
    Zion M; Ben-Yehuda D; Avraham A; Cohen O; Wetzler M; Melloul D; Ben-Neriah Y
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10722-6. PubMed ID: 7938018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research on the epigenetic regulation mechanism of the PTPN6 gene in advanced chronic myeloid leukaemia.
    Zhang X; Yang L; Liu X; Nie Z; Wang X; Pan Y; Luo J
    Br J Haematol; 2017 Sep; 178(5):728-738. PubMed ID: 28480959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant Methylation of Suppressor of Cytokine Signaling 1 (SOCS1) Gene as a Biomarker for Early Prediction and Diagnosis of Bladder Cancer.
    Guan H; Li X; Lu J; Meng L; Guo Y; Dong J; Rong S; Zhao F; Shen H
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines.
    Watanabe D; Ezoe S; Fujimoto M; Kimura A; Saito Y; Nagai H; Tachibana I; Matsumura I; Tanaka T; Kanegane H; Miyawaki T; Emi M; Kanakura Y; Kawase I; Naka T; Kishimoto T
    Br J Haematol; 2004 Sep; 126(5):726-35. PubMed ID: 15327527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1.
    Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C
    J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.